Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Buy
66
MSCI Quote, Financials, Valuation and Earnings
Last price:
$548.06
Seasonality move
:
9.75%
Day range:
$549.49 - $557.86
52-week range:
$468.43 - $642.45
Dividend yield:
1.2%
P/E ratio:
37.83x
P/S ratio:
14.79x
P/B ratio:
--
Volume:
328.5K
Avg. volume:
588.8K
1-year change:
17.85%
Market cap:
$42.6B
Revenue:
$2.9B
EPS (TTM):
$14.55
Analysts' Opinion
-
Consensus RatingMSCI has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $614.53, MSCI has an estimated upside of 11.65% from its current price of $550.41.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $520.00 representing 100% downside risk from its current price of $550.41.
Fair Value
-
According to the consensus of 13 analysts, MSCI has 11.65% upside to fair value with a price target of $614.53 per share.
MSCI vs. S&P 500
-
Over the past 5 trading days, MSCI has overperformed the S&P 500 by 1.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MSCI does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MSCI has grown year-over-year revenues for 46 quarters straight. In the most recent quarter MSCI reported revenues of $745.8M.
Earnings Growth
-
MSCI has grown year-over-year earnings for 1 quarter straight. In the most recent quarter MSCI reported earnings per share of $3.71.
Enterprise value:
46.8B
EV / Invested capital:
13.04x
Price / LTM sales:
14.79x
EV / EBIT:
29.67x
EV / Revenue:
16.01x
PEG ratio (5yr expected):
1.45x
EV / Free cash flow:
33.91x
Price / Operating cash flow:
31.34x
Enterprise value / EBITDA:
26.15x
Gross Profit (TTM):
$2.4B
Return On Assets:
21.04%
Net Income Margin (TTM):
39.08%
Return On Equity:
--
Return On Invested Capital:
30.82%
Operating Margin:
50.55%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.3B | $2.6B | $2.9B | $680M | $745.8M | |
| Gross Profit | $1.9B | $2.2B | $2.4B | $551.5M | $609M | |
| Operating Income | $1.2B | $1.4B | $1.6B | $339.4M | $377M | |
| EBITDA | $1.4B | $1.7B | $1.8B | $391.1M | $432.1M | |
| Diluted EPS | $10.91 | $14.65 | $14.55 | $3.22 | $3.71 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.3B | $1.3B | $1.8B | $1.4B | $1.2B | |
| Total Assets | $4.6B | $4.7B | $5.1B | $5.5B | $5.3B | |
| Current Liabilities | $1.4B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Total Liabilities | $5B | $5.6B | $6B | $6.1B | $6.3B | |
| Total Equity | -$481.6M | -$879.2M | -$901.4M | -$650.5M | -$958.6M | |
| Total Debt | $3.9B | $4.2B | $4.5B | $4.5B | $4.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $1.3B | $1.5B | $300.1M | $301.7M | |
| Cash From Investing | -$85.8M | -$829.9M | -$144.8M | -$32.3M | -$32.9M | |
| Cash From Financing | -$617.6M | -$1B | -$1.5B | -$207.2M | -$321.7M | |
| Free Cash Flow | $1B | $1.2B | $1.4B | $275.9M | $268.9M | |
MSCI
Sector
Market Cap
$42.6B
$600.8M
Price % of 52-Week High
85.67%
84.99%
Dividend Yield
1.2%
2%
Shareholder Yield
3.49%
3.99%
1-Year Price Total Return
17.85%
8.34%
Beta (5-Year)
1.330
0.590
Dividend yield:
1.2%
Annualized payout:
$6.40
Payout ratio:
45.68%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$542.35
200-day SMA
Sell
Level
$574.01
Bollinger Bands (100)
Sell
Level
547.92 - 607.26
Chaikin Money Flow
Buy
Level
134.2M
20-day SMA
Buy
Level
$538.69
Relative Strength Index (RSI14)
Buy
Level
52.20
ADX Line
Buy
Level
14.55
Williams %R
Neutral
Level
-25.3881
50-day SMA
Sell
Level
$554.64
MACD (12, 26)
Sell
Level
-1.86
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
66.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.0177)
Sell
CA Score
(Annual)
Level (-1.9922)
Buy
Beneish M-Score
(Annual)
Level (-2.8327)
Sell
Momentum Score
Level (6)
Sell
Ohlson Score
Level (3.2734)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI’s largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1.7 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI’s all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Stock Forecast FAQ
In the current month, MSCI has received 7 Buy ratings 6 Hold ratings, and 0 Sell ratings. The MSCI average analyst price target in the past 3 months is $614.53.
-
Where Will MSCI Stock Be In 1 Year?
According to analysts, the consensus estimate is that MSCI share price will rise to $614.53 per share over the next 12 months.
-
What Do Analysts Say About MSCI?
Analysts are divided on their view about MSCI share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MSCI is a Sell and believe this share price will drop from its current level to $520.00.
-
What Is MSCI's Price Target?
The price target for MSCI over the next 1-year time period is forecast to be $614.53 according to 13 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is MSCI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MSCI is a Buy. 7 of 13 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MSCI?
You can purchase shares of MSCI via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MSCI shares.
-
What Is The MSCI Share Price Today?
MSCI was last trading at $548.06 per share. This represents the most recent stock quote for MSCI. Yesterday, MSCI closed at $550.41 per share.
-
How To Buy MSCI Stock Online?
In order to purchase MSCI stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 66.32% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 2.61% over the past day.
